Optimization and simplification of transcatheter aortic valve implantation therapy.
Marco BarbantiSimona GulinoGiuliano CostaCorrado TamburinoPublished in: Expert review of cardiovascular therapy (2018)
Transcatheter aortic valve implantation (TAVI) is now a widely adopted therapy for the treatment of elderly patients with severe aortic stenosis. Improved pre-procedural screening, increased operators' experience and technology advancement have made this technique highly reliable and standardized. Areas covered: The purpose of this review article is to provide an overview of the strategies that can be adopted to optimize the TAVI procedure (pre-interventional work-up and procedural simplification and early discharge). Expert commentary: Optimization of TAVI therapy is already a reality and has shown to be safe in most patients, but its penetration has to face with real-world practice. The adoption of a minimalistic and optimized approach requires integration of multidisciplinary competences and an extended, dynamic conception of heart team, which also includes patients' families, referring cardiologist and general practitioners.
Keyphrases
- transcatheter aortic valve implantation
- aortic stenosis
- ejection fraction
- aortic valve replacement
- aortic valve
- transcatheter aortic valve replacement
- end stage renal disease
- left ventricular
- chronic kidney disease
- newly diagnosed
- primary care
- palliative care
- stem cells
- prognostic factors
- heart failure
- healthcare
- coronary artery disease
- patient reported
- minimally invasive
- smoking cessation
- combination therapy